$GEVO Income Statement | Understand Stock

$GEVO

$1.17 +$0.03 (2.63%) Close

$GEVO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of operations

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Ethanol Sales and Related Products
Hydrocarbon
Total revenues

Other revenue
Operating expenses:
Cost of production
Depreciation and amortization, cost
Gross loss
Depreciation and amortization
Restructuring expense
Depreciation, amortization and accretion
Research and development expense
Selling, general and administrative expense (including noncash compensation expense of $7.8 million, $1.5 million and $1.1 million, respectively)
Preliminary stage project costs
General and administrative expense
Project development costs
Acquisition related costs
Facility idling costs
Impairment loss
Loss on disposal of assets
Gain on disposal of assets, net
Total operating expenses

Loss from operations
Other (expense) income
Interest expense
Interest and investment income
(Loss) on modification of 2020 Notes
(Loss) on conversion of 2020/21 Notes to common stock
(Loss) gain from change in fair value of 2020/21 Notes and 2020 Notes embedded derivative liability
Gain on forgiveness of SBA loan
Other income, net
Total other (expense) income, net

Net loss
Net income attributable to redeemable non-controlling interest
Net loss attributed to Gevo, Inc.
Net loss per share - basic and diluted (in dollars per share)
Weighted-average number of common shares outstanding - basic and diluted (in shares)
Net loss per share - basic (in dollars per share)
Net loss per share - diluted (in dollars per share)
Weighted-average common shares outstanding - basic (in shares)
Weighted-average common shares outstanding - diluted (in shares)

Comments